MICROSURGICAL TREATMENT OF MALE FACTOR INFERTILITY
Modern surgical treatment of male infertility requires expertise in microsurgical techniques, including vasectomy reversal (vasovasostomy and vasoepididymostomy), varicocele repair, and testicular sperm retrieval/ biopsy. Dr Dewire's fellowship training and extensive clinical practice afford him an exceptional experience in these complex procedures. He serves as a referral source for urologists and their patients from all over the Wisconsin and northern Illinois.
MEDICAL MANAGEMENT OF MALE FACTOR INFERTILITY
Approximately 30% of men presenting with infertility benefit from non-surgical therapy such as endocrine manipulation for hypogonadism, treatment of poor motility, or management of anti-sperm antibodies. Through his years at Reproductive Specialty Center, Dr. Dewire has effectively treated men with these problems, and has presented data regarding treatment protocols and outcomes at state, regional, and national meetings.
FEMALE UROLOGY/ UROGYNECOLOGY
As part of the minimally invasive surgery portion of the center, advanced treatment for urinary incontinence, prolapse, and pelvic pain syndromes, RSC physicians and staff will continue to utilize diagnostic testing such as cystoscopy, urodynamic studies, and potassium sensitivity testing. The latest incontinence therapies including transobturator tape midurethral sling, periurethral injection, and bone anchor sling are available to patients through the collaborative efforts of Dr. Janik, Koh, and Dewire.
MINIMALLY-INVASIVE TREATMENT OF POST-PROSTATECTOMY INCONTINENCE
Prostate cancer is the most common malignancy in men. Definitive, curative treatments include radical prostatectomy and radiation therapy. About 5% of men develop stress urinary incontinence following radical prostatectomy. For these men, a variation of the "sling" technique used for women has been developed, and is presently being refined at Columbia-St. Mary's, where Dr. Dewire has the largest experience in Wisconsin. Success rates approach 95%, offering these men significantly improved quality of life. The center will offer this exciting new therapy and continue to serve as a referral and training center for urologists throughout the Midwest.
ADVANCED THERAPY FOR ERECTILE DYSFUNCTION
According to the Massachusetts Male Aging Study, 50% of men over the age of 40 experience some degree of sexual dysfunction. The introduction of phosphodiesterase type 5 inhibitors (Viagra, Cialis, Levitra) has revolutionized therapy for ED. Since 30% of men do not respond to oral agents, treatments such as self-injection therapy or a penile prosthesis plan "B" or "C" options for some men. Low testosterone levels are found in 20-30% of men with ED, and most benefit from treatment of their hypogonadism. Dr. Dewire has over 13 years experience managing difficult ED cases, and frequently receives referrals from fellow urologists who lack the experience to treat these men.